Moderna | MRNA - Operating Profit


Moderna reported $-1.39B in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Acadia Pharmaceuticals USD -4.62M 22.01M Mar/2026
Agios Pharmaceuticals USD -110.02M 11.55M Mar/2026
Alnylam Pharmaceuticals USD 137.59M 108.19M Mar/2026
Amgen USD 3.83B 130M Mar/2026
Arrowhead Research USD -141.26M 182.07M Mar/2026
Biogen USD 514.3M 128.8M Mar/2026
BioMarin Pharmaceutical USD 129.65M 68.74M Mar/2026
Celltrion KRW 13.72B 287.31B Dec/2025
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Deva Holding AS TRY 964.87M 240.32M Sep/2023
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Divis Laboratories Ltd INR 8.14B 420M Mar/2026
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
Gilead Sciences USD 2.68B 284M Mar/2026
GlaxoSmithKline GBP 2.29B 856M Mar/2026
Incyte USD 324.17M 59.7M Mar/2026
Ionis Pharmaceuticals USD -118M 97M Mar/2026
Kangmei Pharma CNY -10.94M 15.75M Mar/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Malin Corporation EUR -1.1M 400K Dec/2024
Moderna USD -1.39B 531M Mar/2026
Organigram Holdings CAD -20.13M 7.92M Dec/2025
Ovoca Bio EUR -1.16M 4.48M Jun/2025
Pharma Mar EUR 622K 42.99M Mar/2026
Puma Biotechnology USD 22.08M 24.26M Sep/2024
Qiagen NV USD 121.88M 15.41M Dec/2025
Regeneron Pharmaceuticals USD 744.8M 153.8M Mar/2026
Sangamo BioSciences USD -33.51M 12.77M Jun/2024
Sarepta Therapeutics USD 358.43M 768.52M Mar/2026
Sartorius EUR 160.7M 9.5M Mar/2026
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Tilray USD -20.01M 9.34M Sep/2025
Ultragenyx Pharmaceutical USD -216M 102M Mar/2026
United Therapeutics USD 325.8M 340.4M Mar/2026
Vertex Pharmaceuticals USD 1.14B 124.5M Mar/2026
Zealand Pharma A/S -707.05M 245.73M Dec/2025
Zz Pientze Pharmaceu CNY 837.81M 336.48M Mar/2026